Get startedLog in
    Picture of PhaseBio Pharmaceuticals logo

    PHASQ — PhaseBio Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: PhaseBio Announces Topline Results From Phase 2b Trial For Bentracimab

    Picture of PhaseBio Pharmaceuticals logoPhaseBio Pharmaceuticals
    03/11/2021 12:06
    Nov 3 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO ANNOUNCES TOPLINE RESULTS FROM PHASE 2B TRIAL FOR
BENTRACIMAB
    * PHASEBIO PHARMACEUTICALS INC - TRIAL ACHIEVED PRIMARY
REVERSAL
ENDPOINT IN HEALTHY, OLDER VOLUNTEERS
    * PHASEBIO PHARMACEUTICALS INC - SAFETY, EFFICACY PROFILE OF
BENTRACIMAB IN PHASE 2B TRIAL CONSISTENT WITH PREVIOUSLY
COMPLETED PHASE 1, PHASE 2A TRIALS

Source text for Eikon:  ID:nBw3g0g5qa 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on PhaseBio Pharmaceuticals

    See all news